Bone loss in surgically ovariectomized premenopausal women is associated with T lymphocyte activation and thymic hypertrophy

Journal of Investigative Medicine

Volumn 61, Issue 8, 2013, Pages 1178-1183

  Adeel, Saira ^a   Singh, Karnail ^b   Vydareny, Kay H ^c   Kumari, Meena ^a   Shah, Era ^a   Weitzmann, Mervyn Neale ^a,d   Tangpricha, Vin ^a,d  

^a Department of Medicine   (United States)

^b Department of Surgery ^*  (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Estrogen deficiency; Osteoporosis; T lymphocytes

Indexed keywords

ESTROGEN; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; CD3 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; FOLLITROPIN; GLUTAMINE; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; BONE DENSITOMETRY; BONE DENSITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FAMILY HISTORY; FEMALE; FEMUR NECK; FLOW CYTOMETRY; HUMAN; HYSTERECTOMY; LUMBAR SPINE; MEMORY T LYMPHOCYTE; MENARCHE; MIDDLE AGED; MYOMECTOMY; OBSERVATIONAL STUDY; OSTEOCLAST ACTIVITY; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; OVARY CANCER; PARITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; PREMENOPAUSE; PROSPECTIVE STUDY; PROTEIN EXPRESSION; T CELL CULTURE; T LYMPHOCYTE ACTIVATION; THYMUS; THYMUS HYPERPLASIA; FEMORAL NECK; HYPERTROPHY; MENSTRUATION; PHENOTYPIC VARIATION; POSTMENOPAUSE OSTEOPOROSIS; SAMPLE SIZE; THYMIC HYPERTROPHY; THYMUS DISEASE; VOLUMETRY;

ADULT; BONE DENSITY; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; MIDDLE AGED; OVARIECTOMY; PREMENOPAUSE; PROSPECTIVE STUDIES; T-LYMPHOCYTES; THYMUS HYPERPLASIA;

EID: 84896799684     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0000000000000016     Document Type: Article

References (25)

1. Looker AC, Orwoll ES, Johnston CC, et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997;12:1761-1768. doi: 10.1359/jbmr.1997.12.11.1761.
2. National Osteoporosis Foundation. America's Bone Health: State of Osteoporosis and Low Bone Mass in Our Nation. Washington, DC: National Osteoporosis Foundation; 2002.
3. US Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General; 2004.
4. Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007;22(3): 465-475.
5. Budhia S, Mikyas Y, Tang M, et al. Osteoporotic fractures a systematic review of US healthcare costs and resource utilization. Pharmacoeconomics [serial online]. 2012;30(2):147-170.
6. Ryan MR, Shepherd R, Leavey JK, et al. An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency. Proc Natl Acad Sci U S. A. 2005; 102(46): 16735-16740.
7. Cenci S, Weitzmann MN, Roggia C, et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest. 2000;106:1229-1237.
8. Weitzmann MN, Cenci S, Rifas L, et al. T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms. J Bone Miner Res. 2001;16:328-337.
9. Eghbali-Fatourechi G, Khosla S, Sanyal A, et al. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest. 2003;111(8): 1221-1230.
10. D'Amelio P, Grimaldi A, Bernabei P, et al. Immune system and bone metabolism: does thymectomy influence postmenopausal bone loss in humans? Bone. 2006;39(3):658-665.
11. D'Amelio P, Grimaldi A, Di Bella S, et al. Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. Bone. 2008;43:92-100.
12. Luo CY, Wang L, Sun C, et al. Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro. Cell Mol Immunol. 2011;8(1):50-58.
13. Pido-Lopez J, Imami N, Aspinall R. Both age and gender affect thymic output: more recent thymic migrants in females than males as they age. Clin Exp Immunol. 2001;125(3):409-413.
14. Pacifici R. Role of T cells in ovariectomy induced bone loss - revisited. J Bone Miner Res. 2012;27:231-239. doi: 10.1002/jbmr.1500.
15. Pacifici R. T cells: critical bone regulators in health and disease. Bone. 2010;47(3):461-471. ISSN 8756-3282, 10.1016/j.bone.2010.04.
16. Pacifici R. Estrogen deficiency, T cells and bone loss. Cell Immunol. 2008;252(1-2):68-80, ISSN 0008-8749, 10.1016/j.cellimm.2007.06.00.
17. Roggia C, Gao Y, Cenci S, et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. ProcNatl Acad Sci U S A. 2001;98(24):13960-13965.
18. Cenci S, Toraldo G, Weitzmann MN, et al. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci U S A. 2003;100(18):10405-10410.
19. Gao Y, Qian W-P, Dark K, et al. Estrogen prevents bone loss through transforming growth factor {beta} signaling in T cells. Bone. 2004;101:16618-16623.
20. Gao Y, Grassi F, Ryan MR, et al. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest. 2007;117(1):122-132.
21. Yamaza T, Miura Y, Bi Y, et al. Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents. PLoS ONE. 2008;3(7):e2615. doi:10.1371/journal.pone.0002615.
22. Li J-Y, et al. Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. PNAS. 2011;108(2):768-773.
23. Onal M, Xiong J, Chen X, et al. Receptor activator of nuclear factor JB ligand (RANKL) protein expression by b lymphocytes contributes to ovariectomy-induced bone loss. J Biol Chem. 2012;287(35):29851-29860.
24. Tyagi AM, Srivastava K, Sharan K, et al. Daidzein prevents the increase in CD4+CD28null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect. PLoS One. 2011;6(6):e21216.
25. Yan Li, et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood. 2007;109:3839-3848.